91 related articles for article (PubMed ID: 24458176)
1. Recurrent parathyroid carcinoma appearing as FDG negative but MIBI positive.
Alabed YZ; Rakheja R; Novales-Diaz JA; Lisbona R
Clin Nucl Med; 2014 Jul; 39(7):e362-4. PubMed ID: 24458176
[TBL] [Abstract][Full Text] [Related]
2. Recurrent postoperative parathyroid carcinoma: FDG-PET and sestamibi-SPECT findings.
Neumann DR; Esselstyn CB; Kim EY
J Nucl Med; 1996 Dec; 37(12):2000-1. PubMed ID: 8970522
[TBL] [Abstract][Full Text] [Related]
3. Differential diagnosis between secondary and tertiary hyperparathyroidism in a case of a giant-cell and brown tumor containing mass. Findings by (99m)Tc-MDP, (18)F-FDG PET/CT and (99m)Tc-MIBI scans.
Gedik GK; Ata O; Karabagli P; Sari O
Hell J Nucl Med; 2014; 17(3):214-7. PubMed ID: 25397627
[TBL] [Abstract][Full Text] [Related]
4. Distant subcutaneous recurrence of a parathyroid carcinoma: abnormal uptakes in the (99m)Tc-sestamibi scan and (18)F-FDG PET/CT imaging.
Kim SS; Jeon YK; Lee SH; Kim BH; Kim SJ; Kim YK; Kim IJ
Korean J Intern Med; 2014 May; 29(3):383-7. PubMed ID: 24851075
[TBL] [Abstract][Full Text] [Related]
5. FDG-anorectic parathyroid carcinoma with FDG-avid bone metastasis on PET/CT images.
Li M; Lu H; Gao Y
Clin Nucl Med; 2013 Nov; 38(11):916-8. PubMed ID: 24089062
[TBL] [Abstract][Full Text] [Related]
6. 11C-methionine PET/CT imaging of 99mTc-MIBI-SPECT/CT-negative patients with primary hyperparathyroidism and previous neck surgery.
Traub-Weidinger T; Mayerhoefer ME; Koperek O; Mitterhauser M; Duan H; Karanikas G; Niederle B; Hoffmann M
J Clin Endocrinol Metab; 2014 Nov; 99(11):4199-205. PubMed ID: 25029418
[TBL] [Abstract][Full Text] [Related]
7. Benign Parathyroid Hyperplasia With Incidental Pulmonary Seeding on 99mTc-MIBI Scintigraphy and FDG PET/CT.
Tsai YK; Tsai CJ; Chiu CH; Ko KH; Li YF
Clin Nucl Med; 2022 Mar; 47(3):e329-e330. PubMed ID: 35025795
[TBL] [Abstract][Full Text] [Related]
8. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma.
Fonti R; Salvatore B; Quarantelli M; Sirignano C; Segreto S; Petruzziello F; Catalano L; Liuzzi R; Rotoli B; Del Vecchio S; Pace L; Salvatore M
J Nucl Med; 2008 Feb; 49(2):195-200. PubMed ID: 18199607
[TBL] [Abstract][Full Text] [Related]
9. Potential false positive Tc-99m sestamibi parathyroid study due to uptake in brown adipose tissue.
Wong KK; Brown RK; Avram AM
Clin Nucl Med; 2008 May; 33(5):346-8. PubMed ID: 18431153
[TBL] [Abstract][Full Text] [Related]
10. Tc-99m pertechnetate/sestamibi imaging in a case of recurrent parathyroid carcinoma with metabolic bone disorder.
Meng Z; Tan J; Zhang M; Dong F; Jia Q; Zhang F
Clin Nucl Med; 2009 Jul; 34(7):479-82. PubMed ID: 19542965
[No Abstract] [Full Text] [Related]
11. Clinical utility of F-18 FDG PET/CT in recurrent breast carcinoma.
Manohar K; Mittal BR; Senthil R; Kashyap R; Bhattacharya A; Singh G
Nucl Med Commun; 2012 Jun; 33(6):591-6. PubMed ID: 22334135
[TBL] [Abstract][Full Text] [Related]
12. Comparison of fluorine-18-FDG PET and technetium-99m-MIBI SPECT in evaluation of musculoskeletal sarcomas.
Garcia R; Kim EE; Wong FC; Korkmaz M; Wong WH; Yang DJ; Podoloff DA
J Nucl Med; 1996 Sep; 37(9):1476-9. PubMed ID: 8790197
[TBL] [Abstract][Full Text] [Related]
13. Synchronous Metastatic Breast Carcinoma and Parathyroid Adenoma on 18F-FDG PET/CT and 99mTc-Sestamibi Imaging.
Singh H; Wale DJ; Wong KK; Gross MD; Viglianti BL
Clin Nucl Med; 2019 Feb; 44(2):148-149. PubMed ID: 30418208
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of [99mTC]MIBI and [18F]fluorodeoxyglucose for imaging recurrent medullary thyroid cancer and hyperparathyroidism in MEN 2a syndrome.
Roelants V; Michel L; Lonneux M; Lacrosse M; Delgrange E; Donckier JE
Acta Clin Belg; 2001; 56(6):373-7. PubMed ID: 11881324
[TBL] [Abstract][Full Text] [Related]
15. Conventional gamma and high energy probe for radioguided dissection of metastases in a patient with recurrent thyroid carcinoma with (99m)Tc-MIBI and (18)F-FDG.
Meller B; Sahlmann C; Horstmann O; Gerl J; Baehre M; Meller J
Nuklearmedizin; 2005; 44(3):N23-5. PubMed ID: 15997503
[No Abstract] [Full Text] [Related]
16. A case of parathyroid carcinoma visualized on Tc-99m-sestamibi scintigraphy.
Aigner RM; Fueger GF; Lax S
Nuklearmedizin; 1997 Oct; 36(7):256-8. PubMed ID: 9394362
[TBL] [Abstract][Full Text] [Related]
17. Influence of thyroid-stimulating hormone on 18F-fluorodeoxyglucose and 99mTc-methoxyisobutylisonitrile uptake in human poorly differentiated thyroid cancer cells in vitro.
Kim CH; Yoo IeR; Chung YA; Park YH; Kim SH; Sohn HS; Chung SK
Ann Nucl Med; 2009 Feb; 23(2):131-6. PubMed ID: 19225935
[TBL] [Abstract][Full Text] [Related]
18. Follow-up of differentiated thyroid cancer: what is the value of FDG and sestamibi in the diagnostic algorithm?
Dietlein M; Scheidhauer K; Voth E; Theissen P; Schicha H
Nuklearmedizin; 1998 Jan; 37(1):12-7. PubMed ID: 9467164
[TBL] [Abstract][Full Text] [Related]
19. Technetium-99m MIBI uptake in recurrent parathyroid carcinoma and brown tumors.
Lu G; Shih WJ; Xiu JY
J Nucl Med; 1995 May; 36(5):811-3. PubMed ID: 7738654
[TBL] [Abstract][Full Text] [Related]
20. Detection of late chest wall recurrence of breast carcinoma during Tc-99m sestamibi parathyroid scintigraphy.
Conrad GR; Sloan DA; Sinha P
Clin Nucl Med; 2003 May; 28(5):408-9. PubMed ID: 12702942
[No Abstract] [Full Text] [Related]
[Next] [New Search]
